Steven E. Finkelstein, MD, FACRO

Steven E. Finkelstein, MD, FACRO

Florida Cancer Affiliates / The US Oncology Network

Panama City, FL

Steven E. Finkelstein, MD, FACRO, currently serves as a Co-Chair on the NRG Immunotherapy Committee, Co-Chair of the 2018-2019 ACRO Scientific Program Committee, and is the Chair of the SWOG Radiation STG Committee. He also serves on the Board of Chancellors and is the Chair of Education Committee for ACRO, Editor-in-Chief for Contemporary Radiation Oncology, and Editor of ASCO Publications. Dr. Finkelstein has been National Director of Translational Research Consortium (TRC), the cutting-edge therapy arm of 21st Century Oncology in Scottsdale, Arizona. Dr. Finkelstein is responsible for expanding patient access to advanced cancer care. Inspired by his grandmother, a cancer patient, he became a dedicated cancer surgeon who found that radiation therapy could sometimes do for his patients what surgery could not. Dr. Finkelstein received his medical degree from the University of Michigan Medical School. He served a residency in General Surgery at Washington University in Saint Louis, Missouri, and was Chief Resident in Radiation Oncology at the Moffitt Cancer Center in Tampa, Florida. Dr. Finkelstein also served fellowships in Biologic Immunotherapy Clinical Cancer and Surgical Oncology at the Surgery Branch of the National Cancer Institute, NIH in Bethesda, Maryland. He is a member of the American College of Radiation Oncology, American Medical Association, American Society of Clinical Oncology, American Society for Therapeutic Radiology and Oncology, the Radiological Society of North America, and the Radiation Therapy Oncology Group.

Articles by Steven E. Finkelstein, MD, FACRO

Brachytherapy/Caesium

Steven E. Finkelstein, MD, FACRO, discusses the increasing prevalence of brachytherapy as an option for prostate cancer patients in need of radiation therapy, specifically in the recurrent space. Additionally, he addresses the limitations of the technique and the lack of studies directly comparing brachytherapy to other options.

Read More
  • 1
  • 2

Join the GRU Community

- Why Join? -